Skip to content
DataLookout
Menu

Andrew P. Groves clinical trial pipeline

Get alerts when Andrew P. Groves's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-05

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  1. Notable: Intrathecal Azacitidine and Nivolumab · Recurrent High-grade Glioma Primary and study completion pushed from Mar 2027 to Mar 2028 Andrew P. GrovesPhase 1 NCT06896110
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Active trials by phase

Phase 1
1

Disease areas by active trials

Get alerts when Andrew P. Groves's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free